The UK Surgical Sutures Market was valued at $103.1 Million in 2025 and projected to reach to $139 Million by 2030, representing a compound annual growth rate of CAGR 6.2%. The UK surgical sutures market is positioned for steady growth through 2030, driven by increasing surgical volumes, ageing population demographics, and rising healthcare expenditure.
The UK surgical sutures market is valued at £103.1 million in 2025 and is projected to reach £139.0 million by 2030, demonstrating robust growth potential in the region.
The UK benefits from advanced healthcare infrastructure with extensive NHS coverage and a thriving private healthcare sector, driving consistent demand for high-quality surgical sutures across multiple specialties.
High surgical procedure volumes across UK hospitals and surgical centres, including orthopaedic, cardiovascular, and general surgery, create sustained demand for diverse suture products and innovations.
Strong adoption of innovative suture technologies, including absorbable and synthetic options, reflects the UK market's commitment to advanced surgical practices and improved patient outcomes.
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | COSMETIC & PLASTIC SURGERY (Application) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 6.5% from 2025 to 2030 |
| Largest Segment | SUTURE THREADS (Product) |
| Market Size Base Year (Billions) | ~USD 4.85 (2025) |
| Revenue Forecast (Billions) | ~USD 6.65 (2030) |
| Segments Covered | Product, Nature Of Absorbent, Type, Coating, Application, End User |
6 segment dimensions are covered across the global market.
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| HENRY SCHEIN | United States | Public Company | Dental consumables and equipment (Global Distribution and Value-Added Services – dental),Medical consumables and equipment (Global Distribution and Value-Added Services – medical),Global Specialty Products (implants, endodontics, orthodontics, orthopedics), |
| HEALTHIUM MEDTECH LIMITED | India | Private Company | Sutures and suture materials,Surgical gloves,Meshes, tapes, and wound care, |
| BOSTON SCIENTIFIC CORPORATION | United States | Public Company | Cardiac Rhythm Management & Electrophysiology,Structural Heart & LAAC (including WATCHMAN FLX),Peripheral Interventions & Vascular, |
| ZIMMER BIOMET HOLDINGS, INC. | United States | Public Company | Knee reconstructive products,Hip reconstructive products,S.E.T. (sports medicine, biologics, foot and ankle, upper extremities, trauma, CMFT), |
| STRYKER | United States | Public Company | Orthopaedic Implants (Hip, Knee, Shoulder, Trauma & Extremities),MedSurg Equipment & Patient Handling,Endoscopy, Navigation & Communications Systems, |
| SMITH+NEPHEW | United Kingdom | Public Company | Orthopaedics (knee, hip, trauma, other reconstruction),Sports Medicine & ENT,Advanced Wound Care, |
| CONMED CORPORATION | United States | Public Company | Orthopedic and Sports Medicine (implants, powered resection, visualization),General Surgery (AirSeal, Buffalo Filter, endomechanical, electrosurgical),Endoscopic Technologies (GI therapeutic and diagnostic), |
Henry Schein is a publicly traded United States-based company founded in 1932 with 25,000 employees, operating in the medical and dental supply sector.
Healthium Medtech Limited is an Indian private medical device company founded in 1992 with 779 employees.
Boston Scientific Corporation is a publicly traded United States medical device company founded in 1979 with 59,000 employees.
Zimmer Biomet Holdings, Inc. is a publicly traded United States company founded in 1927 with 17,000 employees, specializing in orthopedic and musculoskeletal devices.
Stryker is a publicly traded United States medical technology company founded in 1941 with 56,000 employees.
Smith+Nephew is a publicly traded United Kingdom-based company founded in 1856 with 16,988 employees, operating in medical devices and healthcare.
ConMed Corporation is a publicly traded United States medical device company founded in 1970 with 3,900 employees.
The UK surgical sutures market is valued at £103.1 million in 2025 and is expected to grow to £139.0 million by 2030.
The UK surgical sutures market is projected to grow at a compound annual growth rate (CAGR) of 6.2% from 2025 to 2030.
Growth in the UK market is driven by increasing surgical procedure volumes, an aging population, rising healthcare expenditure, and growing adoption of advanced absorbable and specialty sutures.
Absorbable sutures and specialty sutures are gaining significant traction in the UK due to their superior performance in complex surgical procedures and reduced infection risk.
The UK surgical sutures market benefits from advanced healthcare infrastructure, strong regulatory standards, and high surgical volumes, positioning it as a mature and stable market within Europe.
This study involved four major activities to estimate the current surgical sutures market size. First, extensive secondary research was conducted to gather information on the market, including related and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were used to estimate the overall surgical sutures market size. After that, market breakdown and data triangulation were applied to estimate the market size of segments and subsegments.
The secondary research process involved the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the surgical sutures market. It was also used to obtain important information about the key players, market classification, and segmentation according to industry trends to the bottom-most level, as well as key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
In the primary research process, various supply and demand sources were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various companies and organizations operating in the surgical sutures market. The primary sources from the demand side included industry experts, purchase & sales managers, doctors, and personnel from research organizations. Primary research was conducted to validate the market segmentation, identify key players, and gather insights on key industry trends and key market dynamics.
A breakdown of the primary respondents for the surgical sutures market is provided below:
Note 1: C-level primaries include CEOs, CFOs, COOs, and VPs.
Note 2: Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
Note 3: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = < USD 1.00 billion.
Source: MarketsandMarkets Analysis
To know about the assumptions considered for the study, download the pdf brochure
For the global market value, annual revenues were calculated based on the revenue mapping of major product manufacturers and OEMs active in the global surgical sutures market. All the major product manufacturers were identified at the global and/or country/regional level. Revenue mapping for the respective business segments/sub-segments was done for the major players. Also, the global surgical sutures market was split into various segments and sub-segments based on:
The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

After arriving at the overall size of the global surgical sutures market through the above-mentioned methodology, this market was split into several segments and subsegments. The data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macro indicators and regional trends from both demand- and supply-side participants.
Surgical sutures, often referred to as stitches, are sterile thread-like materials specifically designed for the closure and repair of skin and tissue lacerations. These sutures play a critical role in surgical procedures, facilitating the closure of incisions and the apposition of internal organs, dermal layers, and soft tissues post-operatively. Their applications extend to various types of wound management, ensuring hemostasis and promoting optimal healing processes through tensile strength and biocompatibility.
Full forecast, segment splits, and company analysis for all Surgical Sutures Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report